30-day average of 13 articles Β· scale β100 to +100
Across 13 scored articles from Oct 16 to Nov 14, 2026 (UTC),
the average sentiment of Oklo news is Neutral (+1)
on a scale from β100 to +100.
That is down 12 points from the previous 30 days (+13).
π° Cash rose to $3.13B via $2.3B stock sales in first nine months of 2026.
π Analysts project $6.3B cash burn 2026-2030, doubling current reserves.
Somewhat Bearish -45
Oklo (NYSE: OKLO) Faces A $6.3 Billion Funding Gap Even After Beating Quarterly Estimates
AI-generated analysis
Key insights
π Analysts project Oklo will consume roughly $6.3 billion in free cash flow between 2026 and 2030, nearly double its current cash reserves of $3.13 billion.
π Craig-Hallum analyst Eric Stine slashed his price target to $27 from $53 due to concerns over Oklo's longer-term capital position despite beating quarterly estimates.
π° Oklo's cash balance improved to $3.13 billion primarily through $2.3 billion in stock sales totaling across the first nine months of 2026.
ποΈ Management reiterated guidance for $400 million to $500 million in plant spending this year but has not disclosed a construction cost for its first Aurora reactor in Idaho.
π The consensus 2027 loss estimate widened to $1.13 per share from $0.96 just 90 days earlier, signaling deteriorating profitability expectations.
π° At current market value, investors are paying approximately $2 billion above Oklo's net cash for a business that has yet to price its first reactor or sign a binding construction contract.
π€ H.C. Wainwright maintains a Buy rating with a $90 price target, suggesting a successful power agreement like the potential deal with Meta could alter the funding calculus.
π Bullish signals
πOklo posted better-than-expected third-quarter results with a loss of $0.22 per share against the $0.27 Wall Street forecast.
π°The company's cash balance improved from $3.0 billion to $3.13 billion, driven by continued stock sales totaling $2.3 billion in the first nine months of 2026.
π€H.C. Wainwright maintains a Buy rating with a $90 price target, suggesting that securing a major power agreement could dramatically alter the company's funding outlook.
π Risk factors
πAnalysts project Oklo will face a $6.3 billion free cash flow gap between 2026 and 2030, requiring fresh equity issuance or debt to fill the hole.
πCraig-Hallum analyst Eric Stine slashed his price target to $27 from $53 due to concerns over Oklo's longer-term capital position despite recent earnings beats.
ποΈManagement has not disclosed a construction cost for its first Aurora reactor in Idaho, leaving investors waiting on critical financial data.
π°At current market value, investors are paying approximately $2 billion above Oklo's net cash for a business that has yet to price its first reactor or sign a binding construction contract.
Article
Nuclear startup Oklo (NYSE: OKLO) faces a significant funding challenge, with analysts projecting a $6.3 billion free cash flow gap between 2026 and 2030 that exceeds its current cash reserves of $3.13 billion. This financial reality has prompted Craig-Hallum analyst Eric Stine to slash his price target from $53 to $27, despite the company posting better-than-expected third-quarter results where it lost $0.22 per share versus a forecasted loss of $0.27.
The company's cash position improved slightly due to $2.3 billion in stock sales during the first nine months of 2026, but management has reiterated guidance for $400 million to $500 million in plant spending this year without disclosing a construction cost for its first Aurora reactor in Idaho. Investors are currently paying approximately $2 billion above Oklo's net cash for a business that has not yet priced its first reactor or signed a binding construction contract, raising concerns about capital adequacy.
While the consensus of 25 analysts maintains a mean price target of $56, their loss estimates are deteriorating with projected 2027 losses widening to $1.13 per share. H.C. Wainwright offers a contrasting Buy rating with a $90 target, suggesting that securing a major power agreement, such as the potential deal with Meta for its Ohio campus, could dramatically alter Oklo's funding calculus and operational outlook.
Sector and industry come from company profile data. Sentiment is the AI score of the news articles on this page, averaged per day. Not investment advice.
Nuclear startup Oklo (NYSE: OKLO) faces a significant funding challenge, with analysts projecting a $6.3 billion free cash flow gap between 2026 and 2030 that exceeds its current cash reserves of $3.13 billion. This financial reality has prompted Craig-Hallum analyst Eric Stine to slash his price target from $53 to $27, despite the company posting better-than-expected third-quarter results where it lost $0.22 per share versus a forecasted loss of $0.27.
The company's cash position improved slightly due to $2.3 billion in stock sales during the first nine months of 2026, but management has reiterated guidance for $400 million to $500 million in plant spending this year without disclosing a construction cost for its first Aurora reactor in Idaho. Investors are currently paying approximately $2 billion above Oklo's net cash for a business that has not yet priced its first reactor or signed a binding construction contract, raising concerns about capital adequacy.
While the consensus of 25 analysts maintains a mean price target of $56, their loss estimates are deteriorating with projected 2027 losses widening to $1.13 per share. H.C. Wainwright offers a contrasting Buy rating with a $90 target, suggesting that securing a major power agreement, such as the potential deal with Meta for its Ohio campus, could dramatically alter Oklo's funding calculus and operational outlook.
π Analysts project $6.3B cash burn 2026-2030, doubling current reserves.
π Craig-Hallum slashed target to $27 citing capital concerns despite earnings beat.
π° Cash rose to $3.13B via $2.3B stock sales in first nine months of 2026.
ποΈ Management guides $400M-$500M plant spending but lacks first reactor construction cost.
π Consensus 2027 loss widened to $1.13/share, signaling deteriorating profitability.
π Analysts project Oklo will consume roughly $6.3 billion in free cash flow between 2026 and 2030, nearly double its current cash reserves of $3.13 billion.
π Craig-Hallum analyst Eric Stine slashed his price target to $27 from $53 due to concerns over Oklo's longer-term capital position despite beating quarterly estimates.
π° Oklo's cash balance improved to $3.13 billion primarily through $2.3 billion in stock sales totaling across the first nine months of 2026.
ποΈ Management reiterated guidance for $400 million to $500 million in plant spending this year but has not disclosed a construction cost for its first Aurora reactor in Idaho.
π The consensus 2027 loss estimate widened to $1.13 per share from $0.96 just 90 days earlier, signaling deteriorating profitability expectations.
π° At current market value, investors are paying approximately $2 billion above Oklo's net cash for a business that has yet to price its first reactor or sign a binding construction contract.
π€ H.C. Wainwright maintains a Buy rating with a $90 price target, suggesting a successful power agreement like the potential deal with Meta could alter the funding calculus.
Bullish Signals
Q3 loss narrowed to $0.22 vs $0.27 forecast.
Cash rose to $3.13B via $2.3B stock sales.
Buy rating with $90 target on power deal.
Risk Factors
Analysts project $6.3B free cash flow gap 2026-2030.
Craig-Hallum analyst slashed target to $27 from $53.
Construction cost for first Idaho reactor remains undisclosed.
Investors pay ~$2B premium without binding construction contract.
Bullish Signals
Oklo posted better-than-expected third-quarter results with a loss of $0.22 per share against the $0.27 Wall Street forecast.
The company's cash balance improved from $3.0 billion to $3.13 billion, driven by continued stock sales totaling $2.3 billion in the first nine months of 2026.
H.C. Wainwright maintains a Buy rating with a $90 price target, suggesting that securing a major power agreement could dramatically alter the company's funding outlook.
Risk Factors
Analysts project Oklo will face a $6.3 billion free cash flow gap between 2026 and 2030, requiring fresh equity issuance or debt to fill the hole.
Craig-Hallum analyst Eric Stine slashed his price target to $27 from $53 due to concerns over Oklo's longer-term capital position despite recent earnings beats.
Management has not disclosed a construction cost for its first Aurora reactor in Idaho, leaving investors waiting on critical financial data.
At current market value, investors are paying approximately $2 billion above Oklo's net cash for a business that has yet to price its first reactor or sign a binding construction contract.
Oklo reported third quarter 2026 sales of US$1.86 million and a net loss of US$41.75 million, marking a widening deficit compared to the prior year. To address future production needs, the company signed a long-term manufacturing agreement with U.S. Forged Rings to secure domestic capacity for large Aurora reactor components from 2030 through 2035 at an integrated North Carolina campus.
This strategic move aims to reduce logistical friction and supply chain risk as Oklo scales multiple Aurora powerhouses, directly supporting its thesis of selling long-term electricity rather than just reactors. However, the deal does not resolve immediate challenges such as the lack of commercial plants or the small US$3.07 million in nine-month sales, leaving the company dependent on execution to manage cash burn and avoid further dilution.
Analyst valuations for Oklo remain highly divergent, with one model projecting a fair value of US$80.55 based on massive revenue growth assumptions, while others suggest a price as low as US$30.00 due to concerns over delayed power sales and uncertain regulatory approvals. The manufacturing reservation is viewed as a capacity win that underpins future recurring power revenue, though operational risks persist regarding costs and binding contract certainty.
π Q3 2026 sales hit US$1.86M amid widening US$41.75M net loss.
π€ Signed long-term manufacturing deal with U.S. Forged Rings for 2030-2035 components.
π Securing production at single North Carolina campus to reduce supply chain risk.
β οΈ Nine-month sales of US$3.07M show gap between operations and fleet goals.
π° Analyst fair value estimates range widely from US$30.00 to US$80.55.
π Oklo reported Q3 2026 sales of US$1.86 million and a widening net loss of US$41.75 million.
π€ The company signed a long-term manufacturing agreement with U.S. Forged Rings for Aurora reactor components from 2030 to 2035.
π Production capacity will be secured at a single integrated North Carolina campus to reduce supply chain risk.
β οΈ Current nine-month sales total only US$3.07 million, highlighting the gap between current operations and future fleet goals.
π° Analyst fair value estimates range widely from US$30.00 to US$80.55 depending on revenue growth assumptions.
π The manufacturing deal supports Oklo's thesis of selling long-term electricity rather than just building reactors.
β³ Investors face operational risks regarding regulatory approvals, costs, and the certainty of binding power contracts.
Bullish Signals
Secured manufacturing deal with U.S. Forged Rings for 2030-2035 capacity.
Deal reduces supply chain risk while scaling Aurora reactors.
Risk Factors
Q3 net loss widened to $41.75M.
Continued losses risk dilution without contracts.
Regulatory delays may increase funding risks.
Bullish Signals
Oklo secured a long-term manufacturing agreement with U.S. Forged Rings to lock in domestic capacity for large Aurora reactor components from 2030 through 2035.
The new arrangement aims to reduce logistical friction and supply chain risk as the company scales multiple Aurora powerhouses over time.
Risk Factors
Oklo reported a third quarter net loss of US$41.75 million, which widened significantly from the prior year.
Analysts warn that continued losses without new contracts or clear regulatory progress could lead to further dilution or higher-risk funding.
Oklo Inc. (NYSE:OKLO) shares surged 22.66% to close at $23.55 following a third-quarter earnings beat that sparked investor interest after a week of declines. The nuclear reactor developer reported Q3 revenue of $1.86 million, significantly exceeding analyst expectations of between $1.01 million and $1.03 million. While the company posted a net loss of $41.7 million for the quarterβa 40% increase from the prior yearβthe loss per share narrowed to $0.22, beating the consensus estimate of a $0.27 loss.
On a nine-month basis, Oklo's financial metrics showed continued growth in activity despite widening losses. Revenue for the first nine months reached $3.07 million compared to zero in the same period last year, while the net loss expanded 92% year-over-year to $123.3 million. The company continues to operate at a loss as it scales its operations and prepares for future commercial deployments of its Aurora reactor technology.
In strategic developments, Oklo announced a new manufacturing agreement with US Forged Rings (USFR) to secure domestic capacity for large reactor components. This partnership aims to resolve potential bottlenecks in the supply chain required for the long-term deployment of the Aurora powerhouses. Under the terms of the deal, Oklo will reserve manufacturing space at USFR's planned industrial campus in Hertford County, North Carolina, with initial component deliveries scheduled to begin in 2030.
π Oklo shares jumped 22.66% after Q3 revenue beat estimates at $1.86 million.
π° Nine-month revenue reached $3.07 million, up from zero the prior year.
π Net loss widened 40% to $41.7M, though loss per share improved.
π€ Oklo secured US Forged Rings for domestic Aurora reactor component capacity.
π Component deliveries under new agreement begin in 2030 through 2035.
π Oklo shares jumped 22.66% to $23.55 as investors reacted positively to Q3 earnings that beat Wall Street expectations.
π° The company reported Q3 revenue of $1.86 million, surpassing analyst estimates which ranged from $1.01 million to $1.03 million.
π Net loss widened 40% year-over-year to $41.7 million in Q3, though the loss per share improved to $0.22 versus a consensus of $0.27.
π On a nine-month basis, Oklo generated $3.07 million in revenue compared to none in the prior year period.
π€ Oklo clinched a new manufacturing agreement with US Forged Rings to secure domestic capacity for Aurora reactor components.
π The partnership reserves production space at USFR's North Carolina campus to support future deployments of the Aurora powerhouse system.
π Initial finished component deliveries under the new agreement are scheduled to begin in 2030 and continue through 2035.
Bullish Signals
Shares rallied 22.66% after Q3 revenue beat.
Revenue hit $1.86M, beating consensus estimates.
Loss per share narrowed to $0.22.
Secured US Forged Rings manufacturing deal.
Risk Factors
Q3 net loss widened 40% to $41.7M.
Nine-month loss surged 92% to $123.3M.
Bullish Signals
Oklo shares rallied 22.66% following Q3 earnings that beat analyst expectations for both revenue and loss per share.
The company achieved $1.86 million in Q3 revenue, significantly exceeding the consensus estimate range of $1.01 million to $1.03 million.
Oklo successfully narrowed its quarterly loss per share to $0.22, beating the market consensus estimate of a $0.27 loss.
The firm secured a strategic manufacturing agreement with US Forged Rings to secure domestic supply chain capacity for its Aurora reactor modules.
Risk Factors
Oklo's net loss widened by 40% year-over-year to $41.7 million in the third quarter, indicating ongoing high burn rates.
On a nine-month basis, the company's net loss increased dramatically by 92% to $123.3 million compared to the prior year.
Nuclear reactor developer Oklo Inc (NYSE:OKLO) saw its shares rise 19% to $22.89 after reporting third-quarter results that beat analyst expectations for both revenue and loss per share. The company reported revenue of $1.86 million, surpassing the consensus estimate of $1.01 million, while its loss per share narrowed to $0.22 compared to an expected $0.27 loss.
Despite the positive beats on a per-share basis, Oklo's quarterly net loss widened significantly to $41.7 million from $29.7 million in the prior year, driven by higher research and development and general and administrative expenses. To fund its aggressive development plans, the company holds a substantial cash position of $3.1 billion in cash, equivalents, and marketable debt securities as of September 30.
Oklo raised $2.3 billion through stock offerings in the first nine months of 2026, while operating activities consumed $110.9 million in cash. The company invested $280.9 million in property, plant, and equipment across its power, fuel, and isotope businesses, with structural work underway at the Aurora-Idaho site pending further safety reviews and startup authorization.
Looking ahead, Oklo targets delivering its first full fuel assembly in 2027, subject to execution and regulatory approvals. For the next 12 months, the company plans to commence construction of the Groves-2 Forge isotope facility as part of its broader investment program to advance its nuclear technology portfolio.
π OKLO shares rose 19% after Q3 revenue beat estimates at $1.86 million.
π° Company holds $3.1 billion in cash and raised $2.3 billion via stock offerings.
βοΈ Net loss widened to $41.7 million due to increased R&D and administrative costs.
ποΈ Structural work continues at Aurora-Idaho pending safety reviews and startup authorization.
βοΈ First full fuel assembly targets 2027 delivery with Groves-2 construction starting soon.
π Oklo shares climbed 19% to $22.89 following a third-quarter where revenue and loss per share beat analyst estimates.
π° The company reported Q3 revenue of $1.86 million, significantly exceeding the $1.01 million consensus expectation.
βοΈ Oklo's quarterly net loss widened to $41.7 million from $29.7 million year-over-year due to increased R&D and administrative costs.
π΅ The company holds $3.1 billion in cash, cash equivalents, and marketable debt securities as of September 30 to support development.
π Oklo raised $2.3 billion via stock offerings during the first nine months of 2026 to fund its expansion.
ποΈ Operating activities used $110.9 million in cash, while capital expenditures on property, plant, and equipment totaled $280.9 million.
π Structural work is underway at the Aurora-Idaho site, though safety reviews and startup authorization are still required before operations begin.
βοΈ Oklo targets delivering its first full fuel assembly in 2027, pending execution success and necessary regulatory approvals.
π The company plans to start construction of the Groves-2 Forge isotope facility within the next 12 months.
Bullish Signals
Shares rose 19% to $22.89 on Q3 revenue beat.
Loss per share narrowed to $0.22 vs $0.27 expected.
Holds $3.1 billion cash and marketable securities.
Raised $2.3 billion via stock offerings in 2026.
Risk Factors
Net loss widened to $41.7M from $29.7M prior year.
R&D and G&A expenses drove increased burn rates.
Bullish Signals
Oklo shares rose 19% to $22.89 as third-quarter revenue of $1.86 million beat the $1.01 million analyst consensus estimate.
The company reported a loss per share of $0.22, which was better than the expected $0.27 loss per share.
Oklo holds a robust balance sheet with $3.1 billion in cash, cash equivalents, and marketable debt securities as of September 30.
The company successfully raised $2.3 billion through stock offerings in the first nine months of 2026 to fund its growth initiatives.
Risk Factors
Oklo's quarterly net loss widened significantly to $41.7 million from $29.7 million a year earlier, indicating increasing burn rates.
Higher research and development and general and administrative expenses contributed to the widening of the company's net loss.
Oklo Inc. (NYSE:OKLO) CFO Richard Bealmear sold 16,727 shares of company stock on November 2nd for a total transaction value of $427,374.85 at an average price of $25.55 per share. The sale was executed under a pre-arranged Rule 10b5-1 trading plan and resulted in a 3.46% decrease in his direct ownership position, leaving him with approximately 467,261 shares valued at roughly $11.9 million.
The company recently reported quarterly earnings on August 7th, posting EPS of ($0.28) which missed the consensus estimate of ($0.16). However, revenue reached $1.21 million, significantly beating analyst expectations of $0.09 million and representing a massive 11,900% year-over-year increase. Analysts currently anticipate an EPS of -1.01 for the current fiscal year.
Research firm sentiment remains mixed with several major institutions adjusting their price targets downward recently. Wedbush initiated coverage with an 'outperform' rating and a $36 target, while Piper Sandler, Barclays, and Canaccord Genuity all reduced their price objectives to $49, $59, and $100 respectively, though maintaining positive or neutral ratings. Institutional ownership stands at 85.03% with notable increases from Bank of America, BNY Mellon, and the Swiss National Bank in the first quarter.
π CFO sold 16,727 shares for $427k under Rule 10b5-1 plan.
π° CFO retains 467,261 shares worth ~$11.9 million after sale.
π Q3 revenue hit $1.21M, a 11,900% jump beating estimates.
πΈ EPS missed at ($0.28) vs consensus of ($0.16).
π Analysts Piper Sandler, Barclays, and Canaccord lowered price targets.
π CFO Richard Bealmear sold 16,727 shares for $427,374.85 on November 2nd under a pre-arranged Rule 10b5-1 trading plan.
π° Following the sale, the CFO retains 467,261 shares valued at approximately $11.9 million.
π Oklo reported Q3 revenue of $1.21 million, a 11,900% year-over-year increase that beat analyst estimates of $0.09 million.
πΈ The company posted an EPS of ($0.28), missing the consensus estimate of ($0.16) by $0.12.
π Piper Sandler reduced its price objective from $55 to $49 while maintaining an 'overweight' rating.
π Barclays lowered its price target from $76 to $59, retaining an 'overweight' stance on the stock.
π Canaccord Genuity decreased its price objective from $125 to $100 with a 'buy' rating.
π¦ Bank of America increased its holdings by 55.3% in Q1, now owning over 620,000 shares.
π¦ BNY Mellon and the Swiss National Bank also lifted their stakes in Oklo during the first quarter.
ποΈ The company is developing the Aurora small modular reactor for carbon-free electricity generation.
βοΈ Oklo is advancing fuel-recycling capabilities to convert used nuclear fuel for advanced reactors.
π The stock trades at a market cap of $4.10 billion with a 52-week high of $123.44 and low of $21.65.
Bullish Signals
Revenue hit $1.21M, beating estimates of $0.09M.
Revenue surged 11,900% year-over-year.
Bank of America raised holdings by 55.3% to 620k shares.
Government fundingNew cooperationRegulatory approvalAI-generated analysis
The US Department of Energy (DOE) has selected Oklo for advanced negotiations under its Surplus Plutonium Utilization Program, a significant milestone for the pre-revenue advanced nuclear firm. This federal initiative aims to convert Cold War-era surplus weapons-grade plutonium into commercial fuel for advanced reactors, providing Oklo with a critical runway and validating its fast-fission technology capable of recycling used nuclear material.
Oklo confirmed it is leading this effort alongside Newcleo, a European advanced nuclear reactor developer. The partnership includes a potential investment of up to $2 billion via a Newcleo-affiliated vehicle to develop advanced fuel fabrication infrastructure in the US. This collaboration adds substantial financial weight and technical execution support to Oklo's commercialization roadmap, shifting the focus toward securing fabrication capacity.
The positive news triggered a sharp 10% rise in Oklo stock, which climbed back above $70 as short covering accelerated the move given an elevated short interest of roughly 19%. Wall Street sentiment has also turned constructive, with Bank of America reinstating coverage with a 'buy' rating and a consensus mean price objective of about $130, indicating potential upside from current levels ahead of upcoming pilot reactor milestones.
πΊπΈ DOE selected Oklo for surplus plutonium conversion negotiations.
π€ Oklo partners with Newcleo on $2B US fuel infrastructure.
π Stock surged 10% after government validated fast-fission tech.
π¦ Bank of America reinstated buy rating with $130 target.
π― Analysts see 85% upside before July pilot milestones.
πΊπΈ The DOE selected Oklo for advanced negotiations under the Surplus Plutonium Utilization Program to convert surplus plutonium into commercial fuel.
π€ Oklo is partnering with Newcleo on a potential $2 billion investment to build US fuel fabrication infrastructure.
π Oklo stock surged 10% and reclaimed key moving averages following the government validation of its fast-fission technology.
π Elevated short interest of roughly 19% contributed to the rapid price spike via forced short covering.
π¦ Bank of America reinstated a 'buy' rating with a $130 price target, citing Oklo as an early SMR leader.
π― The company plans to use surplus plutonium as a bridge fuel for its upcoming commercial reactors.
π Analysts see potential upside of roughly 85% from current levels ahead of July 4 pilot milestones.
Bullish Signals
DOE selected for Surplus Plutonium Utilization Program negotiations.
Fast-fission tech validated by federal recycling initiative.
Newcleo partnership includes potential $2B US investment.
Secured regulatory milestone validating technology and runway.
Bank of America reinstated 'buy' with $130 target.
Risk Factors
Stock down ~35% vs YTD high.
DOE negotiations may stall or delay.
Bullish Signals
The DOE selected Oklo for advanced negotiations under the Surplus Plutonium Utilization Program, providing a government-backed path to commercial fuel.
Oklo's fast-fission technology is uniquely validated by the federal initiative for recycling used nuclear material into commercial energy infrastructure.
A partnership with Newcleo includes a potential $2 billion investment to develop advanced fuel fabrication infrastructure in the US.
The company secured a major regulatory milestone that validates its technology and provides a visible runway for a pre-revenue firm.
Bank of America reinstated coverage with a 'buy' rating and a mean price objective of $130, indicating significant upside potential.
Risk Factors
The stock remains down roughly 35% versus its year-to-date high despite the recent positive catalyst.
A key risk is that DOE negotiations could stall or be delayed into future years, removing the near-term commercialization runway.
Oklo Inc. (OKLO) is scheduled to release its third-quarter 2026 earnings results on November 6, ahead of the market open. Analysts project revenue of $2.2 million compared to zero in the year-ago quarter, with a consensus loss estimate of 29 cents per share. The company has historically missed estimates in three of its last four quarters, averaging a negative earnings surprise of nearly 41% over that period.
On the positive side, OKLO secured Department of Energy approval for its Preliminary Documented Safety Analysis at the Aurora INL site, with excavation nearing completion and a targeted startup date of 2028. Additionally, an agreement with Kiewit supports the initial phase of a planned 1.2-gigawatt Ohio campus intended to supply Meta, while recent acquisitions of ARMEC and Creative Engineers are strengthening its engineering and manufacturing capabilities.
However, significant near-term financial pressures loom as OKLO raised its 2026 operating cash outflow guidance to $120-$150 million and capital expenditure outlook to $400-$500 million. Management indicated that initial isotope revenues are unlikely until early 2027, limiting immediate earnings support despite the company holding approximately $3 billion in cash. The stock has declined roughly 81% over the past year, reflecting investor concerns about profitability challenges and the distance to meaningful commercial revenue.
Zacks Investment Research currently assigns OKLO a Rank #4 (Sell) with an Earnings ESP of +12.28%, which does not conclusively predict an upcoming earnings beat. While long-term growth potential exists in advanced nuclear energy, the combination of rising expenses, continued losses, and a history of missing estimates warrants caution for investors ahead of the quarterly report.
π OKLO releases Q3 2026 earnings on Nov. 6 with $2.2M revenue consensus.
π Zacks Rank #4; missed estimates in three of last four quarters.
β οΈ Raised 2026 cash outflow guidance to $120-$150M due to higher expenses.
π OKLO is set to release Q3 2026 earnings on Nov. 6 with consensus revenue estimates of $2.2 million.
π The company carries a Zacks Rank #4 (Sell) and has missed analyst estimates in three of its last four quarters.
β OKLO secured DOE approval for the Aurora INL safety analysis, supporting its targeted 2028 startup date.
π€ An agreement with Kiewit is underway to support a 1.2-gigawatt Ohio campus intended to supply Meta.
ποΈ Acquisitions of ARMEC and Creative Engineers are strengthening OKLO's engineering and component manufacturing capabilities.
β οΈ OKLO raised its 2026 operating cash outflow guidance to $120-$150 million due to higher project-related expenses.
π° Capital expenditure outlook was increased to $400-$500 million, with spending expected to accelerate in H2 2026.
π The company reported a first-half net loss of $81.6 million and holds approximately $3 billion in cash.
β³ Management indicated initial isotope revenues are more likely to emerge in early 2027 rather than the current quarter.
π OKLO shares have fallen about 81.4% over the past year, trading at 1.34 times book value.
Bullish Signals
DOE approved safety analysis for 2028 startup at Aurora INL.
Kiewit agreement supports 1.2GW Ohio campus for Meta supply.
ARMEC and Creative Engineers acquisitions boost engineering capabilities.
Centrus deal could supply uranium for five powerhouses from 2029.
Risk Factors
Raised 2026 cash outflow guidance to $120-$150M.
Increased capex outlook to $400-$500M for 2026.
Isotope revenues likely delayed until early 2027.
Missed earnings estimates in three of four quarters.
Reported H1 net loss of $81.6M.
Bullish Signals
OKLO secured Department of Energy approval for the Preliminary Documented Safety Analysis at Aurora INL, reinforcing confidence in its targeted 2028 startup.
An agreement with Kiewit is being developed to support the initial phase of a planned 1.2-gigawatt Ohio campus intended to supply Meta.
Acquisitions of ARMEC and Creative Engineers strengthened OKLO's engineering, component manufacturing, and specialized nuclear systems capabilities.
An agreement under development with Centrus Energy could provide high-assay low-enriched uranium for up to five Aurora powerhouses starting in 2029.
Risk Factors
OKLO raised its 2026 operating cash outflow guidance to $120-$150 million from $80-$100 million, reflecting higher project-related expenses.
The company increased its capital expenditure outlook to $400-$500 million from $350-$450 million, with spending accelerating in the second half of 2026.
Management indicated that initial isotope revenues are more likely to emerge in early 2027, limiting earnings support for the upcoming quarter.
OKLO missed the Zacks Consensus Estimate in three of the preceding four quarters with an average negative earnings surprise of 40.9%.
The company reported a first-half net loss of $81.6 million, highlighting continuing profitability challenges despite holding $3 billion in cash.
Two nuclear energy companies, Oklo Inc. (OKLO) and NuScale Power Corp. (SMR), are positioned for third-quarter earnings reports next week, with OKLO scheduled to report before the bell on November 6 and SMR following after market close on November 5.
Analysts project that OKLO will generate approximately $99,000 in revenue for the quarter, accompanied by an expected loss per share of $0.21. In contrast, SMR is anticipated to report significantly higher revenue of $3.84 million with a smaller loss per share of $0.13.
Market sentiment and analyst actions have shifted negatively toward OKLO recently. B. Riley Capital Management lowered its price target for OKLO from $92 to $61 while maintaining a 'Buy' rating, citing a valuation reset driven by high interest rates and a de-risking trend in high-beta names.
Despite the lower price target, the reduction implies roughly 125% upside from the stock's last close. The broader market context shows OKLO has declined over 62% this year, with retail sentiment currently rated as 'bearish' on the platform.
π OKLO releases Q3 earnings on November 6 with estimated $99k revenue and -$0.21 loss per share.
π B. Riley slashed OKLO price target to $61, citing high rates and sector de-risking despite 'Buy' rating.
π» OKLO shares fell 62% YTD as retail sentiment turns bearish amid broader market pressure on growth stocks.
π Analysts see 146% upside from current levels based on a $66.80 average 12-month price target.
π Oklo Inc. (OKLO) is scheduled to release its Q3 earnings results on November 6 before the market bell.
π° Analysts estimate OKLO will report quarterly revenue of approximately $99,000 with a loss per share of $0.21.
π B. Riley Capital Management slashed OKLO's price target from $92 to $61 while maintaining a 'Buy' rating.
π The revised B. Riley target implies approximately 125% upside potential from the stock's last closing price.
π OKLO shares have declined more than 62% year-to-date, reflecting broader market pressure on high-beta growth stocks.
π» Retail sentiment for OKLO is currently classified as 'bearish' according to Stocktwits data.
π¦ B. Riley attributes the valuation reset to elevated interest rates and a de-risking of high-beta names in the sector.
π The 12-month average price target for OKLO stands at $66.80, implying over 146% upside from current levels.
βοΈ Oklo is being compared to NuScale Power (SMR), which has outperformed OKLO this week despite similar sector headwinds.
Bullish Signals
B. Riley maintains 'Buy' rating implying ~125% upside.
12-month avg target of $66.80 suggests >146% upside.
Risk Factors
B. Riley cut target to $61 due to high rates.
Stock fell 62% YTD amid share price pressure.
Retail sentiment is bearish before earnings.
Bullish Signals
Despite a lower price target, B. Riley maintains a 'Buy' rating on the stock, implying approximately 125% upside from the last close.
The 12-month average price target of $66.80 suggests significant long-term potential with over 146% upside from current levels.
Risk Factors
B. Riley lowered its price target from $92 to $61, citing a valuation reset driven by elevated interest rates and de-risking of high-beta names.
The stock has declined more than 62% year-to-date, indicating significant pressure on the share price.
Retail sentiment is currently 'bearish', reflecting negative market perception ahead of earnings.
The article compares investment cases for BWXT and OKLO, focusing on their distinct approaches to the nuclear sector. BWXT is presented as an established player with a robust $8.4 billion backlog in naval propulsion and commercial equipment, generating significant free cash flow expected between $345 million and $360 million for 2026. In contrast, OKLO is characterized by its strategy of owning and operating reactors to generate recurring revenue, though it remains in the development phase with substantial hurdles regarding construction and regulatory approval.
OKLO holds a strategic advantage through a committed customer base, specifically Meta's agreement to deploy its 1.2-gigawatt reactor on an Ohio campus. The company has demonstrated execution capability by reaching criticality at its Groves isotope test reactor in under a year and securing selection for the DOE's Nuclear Energy Launch Pad initiative for its Groves-2 Forge project. However, OKLO faces significant financial headwinds, having incurred a loss of $1.01 per share expected for 2026, compared to BWXT's projected earnings of $4.75 per share.
Financial performance and stock price movements highlight the divergence between the two companies over the last six months. BWXT has lost 35.6% but outperformed OKLO, which fell 58%, resulting in a 22.4 percentage point gap in favor of the established manufacturer. Analyst consensus estimates reinforce this disparity, with BWXT showing an 18.5% earnings growth trajectory while OKLO faces widening losses. The article concludes that BWXT offers a stronger near-term investment case due to its positive earnings and cash flow, whereas OKLO carries higher risk until commercial power plans are fully realized.
π€ OKLO secured Meta commitment for 1.2GW reactor on Ohio campus.
βοΈ OKLO reached criticality at Groves test reactor in under one year.
ποΈ DOE selected OKLO's Groves-2 Forge project for isotope production.
πΈ OKLO holds $3 billion cash to fund development activities.
π OKLO expects 2026 loss of $1.01/share, up 40.3% from prior year.
π BWXT maintains an $8.4 billion backlog in naval propulsion and commercial nuclear equipment, indicating demand outpacing deliveries.
π° BWXT expects to generate between $345 million and $360 million in free cash flow for 2026, funding expansion without heavy reliance on external financing.
π€ OKLO has secured a major customer commitment from Meta for its 1.2-gigawatt reactor deployment on an Ohio campus.
βοΈ OKLO successfully reached criticality at its Groves isotope test reactor in less than a year, validating execution capabilities.
ποΈ OKLO's Groves-2 Forge project was selected for the Department of Energy's Nuclear Energy Launch Pad initiative to produce isotopes like lutetium-177.
β½ OKLO has a letter of intent with Centrus for fuel supply up to five Aurora powerhouses, with potential deliveries starting in 2029.
πΈ OKLO held $3 billion in cash and marketable securities at the end of the second quarter to fund its development activities.
π OKLO incurred an expected loss of $1.01 per share for 2026, representing a 40.3% widening compared to the prior year.
π BWXT's stock price declined 35.6% over six months while outperforming OKLO, which fell 58% during the same period.
π― Analyst consensus estimates project BWXT earnings of $4.75 per share for 2026, up 18.5% from 2025 reported numbers.
Bullish Signals
Meta committed to deploy 1.2GW reactor on Ohio campus.
Risk Factors
Expected 2026 loss widens to $1.01 per share.
Commercial plans face construction and regulatory hurdles.
Commercial generation economics remain unproven.
Bullish Signals
OKLO has secured a definitive customer commitment from Meta to deploy its 1.2-gigawatt reactor on an Ohio campus.
The company demonstrated successful execution by reaching criticality at its Groves isotope test reactor in less than one year.
OKLO's Groves-2 Forge project was selected for the Department of Energy's Nuclear Energy Launch Pad initiative to produce medical isotopes.
OKLO holds $3 billion in cash and marketable securities, providing substantial liquidity for development and operations.
Risk Factors
Analysts expect OKLO to incur a loss of $1.01 per share in 2026, which is 40.3% wider than the year-ago figure.
OKLO's commercial power plans face significant hurdles regarding construction completion and regulatory startup authorization.
The company has not yet established the economics of commercial electricity generation despite success with its isotope test reactor.
Company updateRegulatory approvalAI-generated analysis
Oklo Inc. (NYSE: OKLO) shares have declined 63% year-to-date to $26.28, trading near TD Cowen's Hold price target of $26. The advanced nuclear developer faces significant headwinds including zero commercial revenue and substantial dilution risks associated with its development timeline. While the company possesses a unique closed-loop fuel recycling technology via fast reactors, investors remain skeptical due to the long road ahead before generating power sales.
The article contrasts Oklo's performance with peers like NuScale Power (SMR) and Centrus Energy (LEU). Unlike Centrus, which benefits from current uranium fuel revenue, Oklo relies on future projects and a potential radioisotope producer subsidiary, Atomic Alchemy. The primary catalyst for Oklo is the anticipated demand for electricity from AI data centers, specifically anchored by a master power agreement with Switch, though licensing approval remains the decisive hurdle before commercial operation.
Analysts caution that much of Oklo's customer pipeline consists of non-binding letters of intent and that construction will likely require heavy spending. The central debate for investors is whether the steep decline has fully priced in the risks of a long wait for commercial power sales or if the stock represents a setup for a sharp reversal driven by federal backing under the ADVANCE Act and growing AI energy demand.
π Shares dropped 63% YTD, trading near $26 TD Cowen Hold target.
πΈ Zero revenue faces dilution risks while developing first Idaho powerhouse.
π€ Master agreement with Switch links future to AI data center demand.
β οΈ Licensing approval is the decisive hurdle before selling commercial power.
π Atomic Alchemy subsidiary could generate radioisotope revenue as early as this year.
π Oklo shares have dropped 63% year-to-date to $26.28, trading near TD Cowen's Hold price target of $26.
πΈ The company currently has zero commercial revenue and faces dilution risks as it develops its first Aurora powerhouse at Idaho National Laboratory.
π€ Oklo holds a master power agreement with data center operator Switch, linking its future directly to AI data center electricity demand.
β οΈ Licensing approval remains the decisive hurdle for Oklo before it can begin selling commercial power from its fast-reactor plants.
π Beyond power generation, Oklo owns Atomic Alchemy, a radioisotope producer that could generate revenue as early as this year.
π Peers like Centrus Energy (LEU) fell less severely because they earn revenue today from enriched uranium fuel sales.
π¬ TD Cowen initiated coverage with a Hold rating, citing Oklo's unique closed-loop fuel recycling technology but noting the long timeline to operation.
ποΈ Federal backing for next-generation reactors through the ADVANCE Act provides a foundation for potential stock support.
βοΈ Investors are advised to keep OKLO positions small given the high cash burn and uncertainty surrounding construction costs.
Bullish Signals
Unique closed-loop fuel recycling tech for nuclear power.
Master agreement with Switch ties revenue to AI demand.
Atomic Alchemy may generate non-power revenue this year.
Stock down 63% YTD, pricing in long wait.
Risk Factors
Zero commercial revenue with significant dilution risks.
Customer pipeline relies on non-binding letters of intent.
First plant construction requires heavy dilutive spending.
Bullish Signals
Oklo possesses a unique closed-loop fuel recycling technology utilizing fast reactors, offering a potentially disruptive approach to nuclear power generation.
The company has secured a master power agreement with data center operator Switch, directly tying its future revenue potential to the surging AI data center electricity demand.
Oklo owns Atomic Alchemy, a radioisotope producer that could begin generating revenue as early as this year, providing a non-power revenue stream.
The stock has declined 63% year-to-date, potentially pricing in the long wait for commercial power sales and creating a setup for a sharp reversal if milestones are met.
Risk Factors
Oklo currently has zero commercial revenue and faces significant dilution risks as it attempts to fund the development of its first Aurora powerhouse.
Much of Oklo's customer pipeline consists of non-binding letters of intent, creating uncertainty regarding future contract conversion and revenue realization.
Construction of the first plant is expected to require heavy spending, likely necessitating dilutive financing before any power can be sold commercially.
Oklo shares experienced a significant decline of 61% in 2026, driven by investor skepticism regarding the broader nuclear energy sector and the specific demand for AI power. Despite the company achieving notable technical milestones and securing key regulatory approvals, these positive developments were insufficient to offset market concerns about the viability of its current business model.
The primary reasons for the stock's poor performance include the absence of a commercial license, which is critical for revenue generation, and the company's continued cash burn. Investors remain wary of Oklo's unprofitable operations, viewing the stock as highly speculative given the gap between its technical progress and the ability to generate commercial returns.
Wall Street's caution reflects a broader hesitation toward nuclear energy projects that have not yet demonstrated a clear path to profitability or secured necessary operating licenses. Consequently, even substantive operational advancements failed to move the needle positively on the share price, highlighting the high risk premium associated with Oklo's current stage of development.
π OKLO stock dropped 61% in 2026 due to financial and operational concerns.
β OKLO achieved reactor milestones and secured key regulatory approvals.
β οΈ Lack of commercial license prevents OKLO from generating revenue.
πΈ OKLO burns cash while operating at an unprofitable stage.
π Oklo stock plummeted 61% in 2026 as investors reacted negatively to the company's financial and operational status.
β The company achieved a significant reactor milestone and obtained key regulatory approvals during the period.
β οΈ Investors remain concerned about the lack of a commercial license, which prevents Oklo from generating revenue.
πΈ Oklo continues to burn cash while operating at an unprofitable stage, fueling skepticism among shareholders.
ποΈ Wall Street maintains a cautious stance on nuclear energy projects that have not yet proven their commercial viability.
Bullish Signals
Reached reactor milestone.
Secured key regulatory approvals in 2026.
Demonstrated technical progress.
Risk Factors
Stock fell 61% in 2026 due to lack of commercial license.
Ongoing cash burn from unprofitable operations continues.
Investors view stock as speculative without clear profit path.
Bullish Signals
Oklo reached a significant reactor milestone and secured key regulatory approvals in 2026, demonstrating technical progress in its development efforts.
Risk Factors
Oklo stock fell 61% in 2026 due to the lack of a commercial license and ongoing cash burn from unprofitable operations.
Investors are highly skeptical of Oklo's prospects, viewing the stock as speculative because it has not yet demonstrated a clear path to profitability.
OKLO Inc. has achieved significant regulatory milestones to advance its commercial nuclear deployment strategy. The company secured U.S. Department of Energy approval for the Preliminary Documented Safety Analysis at its Aurora-INL project, enabling progress on final design and construction. Additionally, OKLO's Groves Isotope Test Reactor achieved first criticality in August 2026 under DOE authorization, demonstrating operational capability and regulatory navigation skills.
Beyond these achievements, OKLO is preparing for NRC pre-application activities at its proposed 1.2-gigawatt Ohio power campus and advancing the Groves-2 Forge facility under the Nuclear Energy Launch Pad initiative. The company aims to produce lutetium-177 for cancer treatments initially, leveraging experience from operating facilities to streamline future approvals and establish a scalable framework for expanding its nuclear technology portfolio.
From a market perspective, OKLO trades at a price-to-book ratio of 1.55, which is below the industry average. Analyst consensus reflects a cautious stance with an average brokerage recommendation of 1.96 on a scale of 1 to 5 and a Zacks Rank of 4 (Sell) based on recommendations from 23 brokerage firms.
ποΈ OKLO secured DOE approval for Aurora-IN project safety analysis.
βοΈ Groves reactor achieved first criticality in August 2026.
π Company prepares NRC pre-application for 1.2GW Ohio power campus.
π§ͺ Groves-2 facility will produce lutetium-177 for cancer treatments.
π OKLO trades at 1.55 price-to-book ratio, below industry average.
ποΈ OKLO secured DOE approval for the Preliminary Documented Safety Analysis at its Aurora-INL project, enabling further design and construction progress.
βοΈ The company's Groves Isotope Test Reactor achieved first criticality in August 2026 under DOE authorization, validating regulatory navigation capabilities.
π OKLO is preparing NRC pre-application activities for a proposed 1.2-gigawatt Ohio power campus focused on commercial isotope production.
π§ͺ The Groves-2 Forge facility will initially focus on producing lutetium-177, a critical isotope used in cancer treatments.
π OKLO currently trades at a price-to-book ratio of 1.55, which is below the industry average.
π Analyst sentiment remains cautious with an average brokerage recommendation of 1.96 (Buy/Hold/Sell scale) and a Zacks Rank of 4 (Sell).
Bullish Signals
DOE approved safety analysis for Aurora-INL project.
Achieved first criticality at Groves reactor in Aug 2026.
Advancing Groves-2 Forge facility for isotope production.
Risk Factors
Analyst consensus is cautious with an average rating of 1.96/5 and Zacks Rank 4 (Sell).
Trades at P/B of 1.55, below industry average, signaling market skepticism on growth.
Bullish Signals
OKLO achieved DOE approval for the Preliminary Documented Safety Analysis at its Aurora-INL project, enabling critical progress on final design, construction, and procurement activities.
The company successfully achieved first criticality at its Groves Isotope Test Reactor in August 2026 under DOE authorization, demonstrating proven ability to navigate regulatory requirements.
OKLO is advancing the Groves-2 Forge facility under the Nuclear Energy Launch Pad initiative with plans to pursue NRC licenses for commercial isotope production.
Risk Factors
Analyst consensus reflects a cautious stance with an average brokerage recommendation of 1.96 on a scale of 1 to 5 and a Zacks Rank of 4 (Sell) based on recommendations from 23 brokerage firms.
OKLO currently trades at a price-to-book ratio of 1.55, which is below the industry average, suggesting potential undervaluation or market skepticism regarding its growth prospects.
Oklo Inc. (NYSE:OKLO) insider Alexandra Renner sold 688 shares of the company on Wednesday, October 14th, to cover tax withholding obligations related to the vesting of equity awards. The transaction occurred at an average price of $30.75 per share, totaling approximately $21,156. Following the sale, Renner retains direct ownership of 478,428 shares, valued at roughly $14.7 million, representing a negligible 0.14% decrease in her total stake.
The company recently reported its earnings for the quarter ended July 31st on August 7th, where it posted revenue of $1.21 million, significantly beating analyst expectations of $900,000 with a year-over-year increase of nearly 12,000%. However, the company missed consensus estimates for earnings per share, reporting a loss of $0.28 compared to an expected loss of $0.16. Analysts currently anticipate Oklo will report an EPS of -$1.02 for the current fiscal year.
Institutional interest in Oklo remains robust, with hedge funds and banks adjusting their positions significantly in recent quarters. Notable activity includes Bank of America increasing its stake by 55.3% to own over $30 million worth of shares, while Rockefeller Capital Management surged its holdings by 427.1%. Brokerage sentiment is mixed but generally positive, with ratings ranging from 'Strong Buy' to 'Buy' and an average price target of $82.44, despite the stock trading below its 50-day moving average.
π° Revenue hit $1.21M, far beating the $0.09M analyst expectation.
π EPS missed guidance at -$0.28 versus consensus of -$0.16.
π¦ Bank of America raised stake by 55.3% to own ~$30.7M.
π Rockefeller Capital boosted position by 427.1%, adding 138,659 shares.
π― Analysts rate 'Moderate Buy' with $82.44 price target above current price.
π Insider Alexandra Renner sold 688 shares for $21,156 to cover tax withholding obligations, retaining a stake of 478,428 shares.
π° Oklo reported quarterly revenue of $1.21 million, which exceeded analyst expectations of $0.09 million by a wide margin.
π The company missed earnings guidance with actual EPS of -$0.28 versus the consensus estimate of -$0.16.
π¦ Bank of America increased its stake in Oklo by 55.3% to own approximately $30.7 million in shares during the first quarter.
π Rockefeller Capital Management boosted its position by 427.1%, acquiring an additional 138,659 shares in the fourth quarter.
π― Analysts maintain a 'Moderate Buy' average rating with a consensus price target of $82.44, significantly higher than the current trading price.
π Oklo continues to develop its flagship Aurora compact nuclear power plant designed for industrial and commercial energy supply.
π The stock trades at a negative P/E ratio of -32.02 with a market capitalization of $5.60 billion.
Bullish Signals
Revenue surged 11,900% YoY to $1.21M.
Bank of America increased stake by 55.3%.
Rockefeller Capital lifted stake by 427.1%.
Piper Sandler and HC Wainwright rate 'buy'.
Aurora plant targets carbon-free electricity.
Risk Factors
Missed estimates with $0.28 loss vs $0.16 expected.
Trading below $39.36 50-day and $50.54 200-day averages.
Bullish Signals
Oklo reported quarterly revenue of $1.21 million, which was 11,900% higher than the previous year and significantly beat analyst expectations of $0.09 million.
Bank of America Corp DE increased its stake by 55.3% to own 620,281 shares worth approximately $30.76 million, signaling strong institutional confidence.
Rockefeller Capital Management L.P. lifted its stake by 427.1%, acquiring an additional 138,659 shares valued at roughly $12.28 million in the fourth quarter.
Multiple major brokerages maintain bullish or neutral-to-bullish ratings, with Piper Sandler and HC Wainwright issuing 'overweight' and 'buy' ratings respectively.
The company is advancing its flagship Aurora compact nuclear power plant technology aimed at providing reliable, carbon-free electricity to large energy users.
Risk Factors
Oklo missed analyst earnings estimates for the quarter, reporting a loss of $0.28 per share compared to the expected loss of $0.16.
The stock is trading below its 50-day simple moving average of $39.36 and its 200-day simple moving average of $50.54, indicating recent price weakness.
Oklo Inc. (NYSE:OKLO) General Counsel Vivek Narayanadas sold 364 shares of the company's stock on Friday, October 9th, for a total value of $12,627.16 at an average price of $34.69 per share. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan specifically to cover tax withholding obligations related to the vesting of equity awards. Following this sale, Narayanadas retains direct ownership of 8,769 shares, valued at approximately $304,196.61, representing a 3.99% decrease in his total holdings.
Oklo reported its quarterly earnings results on Friday, August 7th, delivering revenue of $1.21 million which significantly beat analyst estimates of $0.09 million, marking an 11,900% year-over-year increase. Despite the strong top-line growth, the company posted a loss of $0.28 per share, missing consensus estimates of a smaller loss of $0.16. The stock currently trades with a market capitalization of $5.92 billion and has seen significant institutional interest, with hedge funds and institutional investors owning 85.03% of the company's outstanding shares.
Analyst sentiment regarding Oklo remains mixed as major financial institutions have recently adjusted their price targets downward. UBS Group reduced its target price from $55.00 to $41.00 with a neutral rating, while Citigroup lowered its target from $76.00 to $57.50, also maintaining a neutral stance. Conversely, Truist Financial set a higher price objective of $51.00 in late September, and Barclays maintains an overweight rating with a target of $76.00. The consensus rating among sell-side analysts is currently 'Moderate Buy' with an average price target of $82.44.
π Vivek Narayanadas sold 364 shares for $12,627.16 under Rule 10b5-1 plan.
π Revenue hit $1.21M, up 11,900% YoY and beating analyst estimates.
π° Loss of $0.28 per share missed consensus estimate of $0.16 loss.
π¦ Institutional investors own 85.03% with Accel and Thor adding positions.
π UBS cut target to $41; Citigroup lowered target to $57.50.
π Oklo General Counsel Vivek Narayanadas sold 364 shares for $12,627.16 to cover tax withholding obligations under a pre-arranged Rule 10b5-1 trading plan.
π Oklo reported quarterly revenue of $1.21 million, which was 11,900% higher than the previous year and significantly beat analyst estimates of $0.09 million.
π° The company posted a loss of $0.28 per share for the quarter, missing consensus estimates of a smaller loss of $0.16 per share.
π¦ Institutional investors and hedge funds own 85.03% of Oklo's stock, with several firms like Accel Wealth Management and Thor Investment Management adding new positions in Q3.
π UBS Group reduced its price target on Oklo from $55.00 to $41.00 and assigned a neutral rating in a recent research note.
π Citigroup decreased its price target on Oklo from $76.00 to $57.50 while maintaining a neutral rating on the stock.
π Truist Financial set a price objective of $51.00 for Oklo shares in a research report dated September 28th.
π Oklo is developing compact nuclear power plants, including its flagship Aurora system, designed to provide carbon-free electricity to industrial and commercial users.
π¬ The company is actively pursuing partnerships and regulatory work in the United States, with initial focus on serving the U.S. market and activities at Idaho National Laboratory.
π Oklo has a market capitalization of $5.92 billion and a beta of 1.20, indicating higher volatility relative to the broader market.
Bullish Signals
Revenue hit $1.21M, up 11,900% YoY.
Institutional ownership stands at 85.03%.
Truist set a $51 price target.
Risk Factors
Loss widened to $0.28, missing smaller loss estimate of $0.16.
UBS cut price target from $55 to $41 with neutral rating.
Citigroup lowered price target from $76 to $57.50.
Bullish Signals
Oklo reported quarterly revenue of $1.21 million, which was 11,900% higher than the previous year and significantly beat analyst estimates of $0.09 million.
Institutional investors and hedge funds own 85.03% of the company's stock, indicating strong confidence from major market participants.
Truist Financial set a price objective of $51.00 for Oklo shares in a research report dated September 28th.
Risk Factors
Oklo posted a loss of $0.28 per share for the quarter, missing consensus estimates of a smaller loss of $0.16 per share.
UBS Group reduced its price target on Oklo from $55.00 to $41.00 and assigned a neutral rating in a recent research note.
Citigroup decreased its price target on Oklo from $76.00 to $57.50 while maintaining a neutral rating on the stock.
Oklo Inc. has been selected by the U.S. Department of Energy's National Reactor Innovation Center (NRIC) to advance its Groves 2 Forge project under the Nuclear Energy Launch Pad initiative. This selection validates Oklo's strategic focus on integrating historical fragmented parts of the isotope value chain, specifically combining reactor irradiation with hot-cell processing capabilities for isotope separation, product recovery, packaging, and transportation.
The facility will primarily focus on producing lutetium-177 and other therapeutic isotopes essential for manufacturing radiopharmaceutical treatments. By building upon the demonstration experience gained from Oklo's existing Groves Isotope Test Reactor, this project aims to generate the necessary operating experience to support a future transition to commercial-scale isotope production with appropriate regulatory licenses.
This advancement supports broader U.S. goals to expand domestic production and processing capacity for critical isotopes. The initiative seeks to reduce supply chain risks by bringing production closer to customers while addressing growing demand across essential industries, positioning Oklo as a key developer in the DOE's streamlined pathway for nuclear fuel cycle advancements.
ποΈ DOE NRIC selected Oklo for Groves 2 Forge project under Nuclear Energy Launch Pad.
βοΈ Facility integrates reactor irradiation with hot-cell processing for isotope separation and recovery.
π Primary focus is producing lutetium-177 therapeutic isotopes for radiopharmaceutical treatments.
π Project leverages existing Groves Isotope Test Reactor experience for commercial-scale production.
π Oklo will gain operating experience to secure licenses for future commercial operations.
ποΈ Oklo Inc. was selected by the U.S. Department of Energy's NRIC to advance its Groves 2 Forge project under the Nuclear Energy Launch Pad initiative.
βοΈ The Groves 2 Forge facility will integrate reactor irradiation with hot-cell processing capabilities, including isotope separation and product recovery.
π Oklo's primary focus for this facility is producing lutetium-177 and other therapeutic isotopes for radiopharmaceutical treatments.
π This project builds on experience from Oklo's existing Groves Isotope Test Reactor to prepare for commercial-scale production.
πΊπΈ The initiative aims to expand U.S. domestic capacity to reduce supply chain risks and meet growing demand for critical isotopes.
π Oklo plans to generate the operating experience needed to secure appropriate licenses for future commercial operations.
Bullish Signals
DOE selected Groves 2 Forge project for isotope production.
Streamlined pathway for domestic reactor development via DOE.
Integrates fragmented isotope value chain into comprehensive facility.
Focuses on high-demand therapeutic isotopes like lutetium-177.
Supports U.S. goals to reduce supply chain risks.
Bullish Signals
Oklo Inc. has been officially selected by the U.S. Department of Energy's NRIC to advance its Groves 2 Forge project, validating its technology and strategic focus on isotope production.
The selection provides a streamlined pathway for domestic reactor development and nuclear fuel cycle advancements through the DOE's Nuclear Energy Launch Pad initiative.
Oklo's Groves 2 Forge will integrate historical fragmented parts of the isotope value chain, creating a comprehensive facility for irradiation, processing, and purification.
The project focuses on high-demand therapeutic isotopes like lutetium-177, positioning Oklo to capture significant growth in the radiopharmaceutical market.
Advancing Groves 2 Forge directly supports U.S. strategic goals to reduce supply chain risks and bring critical isotope production closer to customers.
Capital raisingFinancial outlookAI-generated analysis
Oklo (NYSE: OKLO) shares fell to a fresh 52-week low of $33.70 on October 8, trading at $34.57 as market sentiment shifted sharply against the nuclear startup. The stock's enterprise value contracted by 75% from September levels to approximately $3.97 billion, reflecting a significant drop in valuation multiples from 23.66 times book value to just 1.95 times.
Analysts project that Oklo will face substantial negative free cash flow through 2030, with annual burn rates escalating from roughly $520 million in 2026 to approximately $2.7 billion by 2030. This trajectory creates a cumulative funding gap of about $6.5 billion beyond the company's existing cash reserves, raising questions about how the firm will finance its massive capital spending and deployment plans without new equity issuance.
Company leadership has outlined strategies to mitigate these costs, including advance payments from partners like Meta Platforms and Equinix, and potential customer contributions for fuel procurement via a letter of intent with Centrus Energy. However, until definitive agreements are signed clarifying who absorbs build-out and fuel prepayment costs, equity markets remain the primary funding mechanism, with Oklo maintaining a $1 billion at-the-market program.
Wall Street maintains a mean price target of approximately $76, implying significant upside from current levels, though analyst sentiment has moderated recently. The consensus includes 8 Buy and 6 Outperform ratings alongside 9 Hold and 1 Underperform, with targets ranging widely from $14 to $130. Investors are closely watching the upcoming third-quarter earnings report in November for clarity on new contract terms and funding arrangements.
π Shares hit 52-week low of $34.57 as enterprise value dropped 75%.
πΈ Analysts forecast negative cash flow through 2030 with burn reaching $2.7 billion.
π¦ Company faces $6.5 billion funding shortfall exceeding current cash reserves by 2030.
π€ Advance payments from Meta and Equinix offset some capital expenditure needs.
π Mean price target of $76 suggests roughly 119% upside from recent close.
π Oklo shares hit a fresh 52-week low of $33.70, trading at $34.57 as enterprise value dropped 75% to $3.97 billion.
πΈ Analysts forecast negative free cash flow through 2030, with annual burn growing from $520 million in 2026 to $2.7 billion by 2030.
π¦ The company faces a cumulative funding shortfall of roughly $6.5 billion between 2026 and 2030, exceeding its current cash reserves.
π€ Oklo has received advance payments from Meta Platforms and Equinix to offset some capital expenditure needs.
β‘ A letter of intent with Centrus Energy covers fuel for up to five Aurora powerhouses, with deliveries expected in 2029.
π Wall Street analysts maintain a mean price target of $76, suggesting roughly 119% upside from the October 8 close.
π Analyst consensus includes 8 Buy/Outperform ratings and 9 Hold/Underperform ratings with targets ranging from $14 to $130.
ποΈ Equity issuance remains the primary funding mechanism until customer capital covers a greater share of build-out costs.
π The next key milestone is a definitive agreement with Centrus Energy regarding fuel prepayment cost allocation.
π Oklo's third-quarter earnings report is expected around November, potentially revealing new contract terms.
Bullish Signals
Secured advance payments from Meta and Equinix for deployment.
Risk Factors
Negative free cash flow expected through 2030, burn growing to $2.7B annually.
Cumulative funding gap reaches $6.5B due to massive cash shortfall.
Shares hit 52-week low of $33.70, trading at 1.95x book value.
Mean price target slipped from $89 to $76 as sentiment moderated.
Bullish Signals
Oklo has secured advance payments from major partners Meta Platforms and Equinix to help offset capital expenditure needs for powerhouse deployment.
The company maintains a $1 billion at-the-market equity program signed on September 11 to serve as the primary funding mechanism until customer contributions increase.
A letter of intent with Centrus Energy covers fuel procurement for up to five Aurora powerhouses, potentially reducing direct capital investment per megawatt over time.
Wall Street analysts maintain a mean price target of approximately $76, implying roughly 119% upside from the October 8 closing price.
The company has received advance payments from Meta and Equinix, indicating growing commercial interest in its nuclear technology.
Risk Factors
Analysts expect Oklo to generate negative free cash flow every year through 2030, with annual burn growing from roughly $520 million in 2026 to approximately $2.7 billion in 2030.
The cumulative free cash flow shortfall from 2026 through 2030 totals roughly $6.7 billion, creating a massive funding gap of approximately $6.5 billion that remains outstanding.
Shares fell to a fresh 52-week low of $33.70 on October 8, trading at only 1.95 times book value compared to 23.66 times at the September peak.
The definitive agreement with Centrus Energy has not yet been signed, leaving fuel funding terms unresolved and delaying clarity on cost allocation.
Analyst sentiment has moderated recently, causing the mean price target to slip from around $89 at June 30 to approximately $76 as of October 8.
Capital raisingCompany updateFinancial outlookAI-generated analysis
Oklo (OKLO) shares hit a new 52-week low of $34.57 on October 8, trading at an enterprise value of approximately $4 billion, down significantly from September levels. The market currently values the company's operations at roughly $1.5 billion beyond its net cash position, reflecting a valuation multiple of 1.95 times book value compared to 23.66 times just months prior.
Analyst consensus forecasts negative free cash flow for Oklo through 2030, with capital spending projected to reach nearly $1.9 billion annually by the decade's end. While total estimated burn from 2026 to 2030 is roughly $6.7 billion, analysts assume around $2.2 billion in net cash remains at year-end 2030, implying billions in new funding will be required without a specified source.
Revenue estimates remain thin relative to the massive capital requirements, with consensus revenue rising only modestly from $200 million to $315 million by 2030. CEO Jacob DeWitte highlighted potential models where third-party capital funds deployment, noting that discussions regarding payments from partners like Meta and Equinix are advancing, though specific amounts remain undisclosed.
The company is seeking to reduce its direct capital investment per megawatt deployed through customer contributions for fuel prepayments under a letter of intent with Centrus Energy. A definitive agreement covering up to five Aurora powerhouses is pending, with deliveries expected to begin in 2029, while Oklo maintains a $1 billion at-the-market program signed in September.
π OKLO shares hit a new 52-week low of $34.57, down 80% from the year's high.
π° Enterprise value stands at $4 billion with capital spending nearing $1.9 billion annually through 2030.
π€ Meta and Equinix payment discussions are advancing to fund powerhouse deployment.
β‘ Centrus Energy agreement covers up to five Aurora powerhouses with fuel prepayments starting in 2029.
π Revenue estimates rise from $200 million in 2026 to $315 million by 2030; mean price target is $76.
π Oklo shares closed at $34.57 on October 8, setting a new 52-week low and trading down 80% from the year's high.
π° The company's enterprise value is approximately $4 billion, with analysts expecting negative free cash flow through 2030 as capital spending approaches $1.9 billion annually.
π€ CEO Jacob DeWitte stated that discussions regarding payments from Meta and Equinix are advancing to help fund powerhouse deployment.
β‘ A letter of intent with Centrus Energy covers up to five Aurora powerhouses, potentially allowing customer contributions for fuel prepayments starting in 2029.
π Analyst consensus revenue estimates rise from $200 million in 2026 to $315 million by 2030, while the mean price target is approximately $76.
Bullish Signals
Meta/Equinix payments advance, reducing capital needed per MW.
Centrus deal enables customer fuel prepayments over equity.
Risk Factors
Negative free cash flow forecasted through 2030.
Enterprise value dropped 75% since Sept 30, 2025.
Revenue estimates thin relative to capital needs.
Bullish Signals
CEO Jacob DeWitte indicated that discussions regarding payments from Meta and Equinix are advancing, potentially reducing the amount of direct capital Oklo must invest per deployed megawatt.
A letter of intent with Centrus Energy covers up to five Aurora powerhouses, creating a pathway for customer contributions to cover fuel prepayments rather than relying solely on equity.
Risk Factors
Analysts forecast negative free cash flow every year through 2030, with total estimated capital spending from 2026 to 2030 reaching roughly $6.7 billion.
The company's enterprise value dropped 75% since September 30, 2025, and the mean analyst target fell from around $89 to approximately $76.
Revenue estimates are thin relative to capital needs, with consensus revenue rising only modestly to $315 million by 2030 despite massive deployment plans.
Capital raisingFinancial outlookRegulatory approvalAI-generated analysis
Oklo Inc. (NYSE: OKLO) shares have declined approximately 46% in 2026, trading around $38.57 to $39, despite a Wall Street analyst from Tigress Financial setting a $130 price target that implies roughly 240% upside. The stock's significant drop is attributed to heavy share issuance, where the company raised $1.9 billion through at-the-market programs in 2026, alongside rising capital expenditures and cash burn guidance increased to between $120 million and $150 million for the year.
The company is developing the Aurora INL sodium-cooled fast reactor, which received preliminary safety analysis approval from the Department of Energy with a target startup date in 2028. Oklo has demonstrated execution capability by achieving first criticality at its Groves facility just over 11 months after groundbreaking and holds $3 billion in cash and securities to fund operations until revenue generation begins.
Analyst sentiment remains mixed, with an average consensus price target of $75.78 across 25 analysts implying about 96% upside, though recent earnings revisions have been negative. The stock is viewed as a key play on AI power demand due to a 12 GW master power agreement with Switch, but investors face risks related to cost overruns, potential delays in the 2028 startup timeline, and further dilution from equity raises if customer capital does not cover expansion costs.
π Shares fell 46% in 2026 amid SMR sector selloff, trading near $38.57-$39.
π° Raised $1.9B via ATM; cash burn guidance increased to $120M-$150M.
ποΈ Achieved first criticality at Groves facility over 11 months after groundbreaking.
π€ Signed 12 GW master agreement with Switch for AI data center power.
π Analysts target $75.78, implying ~96% upside from current trading levels.
π Oklo shares have fallen nearly 46% in 2026 to trade around $38.57-$39, reflecting a broader sector-wide selloff in small modular reactor (SMR) stocks.
π° The company raised $1.9 billion via at-the-market equity programs in 2026 and increased its 2026 cash burn guidance to $120M-$150M while lifting capital spending to $400M-$500M.
ποΈ Oklo successfully achieved first criticality at the Groves facility over 11 months after groundbreaking, validating its ability to build reactors on schedule.
π The Aurora INL reactor is targeted for startup in 2028 following preliminary safety analysis approval from the Department of Energy.
π΅ Oklo holds $3 billion in cash and securities as of quarter-end, providing a substantial buffer against near-term funding pressures.
π€ A 12 GW master power agreement with Switch positions Oklo as a primary beneficiary of surging AI data center power demand.
π Tigress Financial analyst Ivan Feinseth initiates coverage with a Buy rating and a $130 price target, citing the own-and-operate model and fuel recycling advantages.
π¬ Management expects to begin generating isotope revenue in the first part of next year (2027) from its reactor operations.
π Earnings estimates for 2026 have turned sharply negative, with average EPS estimates falling to -$0.94 from -$0.70 over the past 90 days.
π― The consensus analyst price target sits at $75.78 across 25 analysts, implying approximately 96% upside from current levels.
β οΈ Investors face risks of cost escalations, potential delays to the 2028 startup date, and further share dilution if expansion costs exceed customer capital contributions.
π Oklo trades below its 50-day moving average of $40.61 and significantly below its 200-day moving average of $59.46.
Bullish Signals
Achieved criticality in 11 months, showing strong execution.
Holds $3B cash buffer until commercial revenue starts.
Secured 12 GW master agreement with Switch for AI demand.
Analyst initiates Buy with $130 target, implying 240% upside.
DOE approved safety analysis, clearing major regulatory hurdle.
Risk Factors
Shares fell 46% in 2026, trading below moving averages.
Raised $1.9B via dilution, signaling heavy reliance on equity.
Cash burn guidance rose to $120M-$150M for 2026.
EPS estimates worsened to -$0.94 from -$0.70 recently.
Oklo (NYSE: OKLO) shares have declined approximately 69% over the past year, yet the company recently achieved a significant operational milestone with its Groves isotope reactor reaching first criticality in early August 2026. This event occurred less than a year after construction began, demonstrating proven execution capabilities that analysts suggest are not yet fully reflected in the current stock price. The achievement validates Oklo's technical ability to build and operate a commercial-scale reactor.
Financially, Oklo holds a robust cash position of roughly $3 billion in marketable securities, which covers about 45% of its market capβnearly double that of peer NuScale Power. Analysts at 24/7 Wall St. maintain a price target of $75.78, implying over 100% upside from the current trading level, based on this cash cushion and the potential for early revenue generation from isotope production expected in the first half of next year.
Looking forward, Oklo aims to start up its Aurora INL power plant by 2028 following recent DOE approval of its preliminary safety analysis. The company has also signed a memorandum of understanding with Kiewit for a larger 1.2 gigawatt campus in Ohio and secured a 12 GW customer agreement with Switch. However, risks remain regarding the total cost of the Aurora project, potential acceleration of share sales via ATM programs, and the finalization of agreements for Centris fuel and surplus plutonium from the DOE.
π Oklo achieved first criticality in August 2026, proving rapid execution capability.
π° Company holds $3B cash covering 45% of market cap versus 24% for peers.
π Analysts target $75.78, implying over 100% upside from current ~$36 price.
β‘ Early isotope revenue expected to start in first part of next year.
β οΈ Management raised 2026 cash use guidance to $120M-$150M due to spending.
π Oklo's Groves isotope reactor achieved first criticality in early August 2026, less than a year after construction began, proving execution capability.
π° The company holds approximately $3 billion in cash and marketable securities, covering 45% of its market cap compared to roughly 24% for peer NuScale Power.
π Analysts at 24/7 Wall St. set a price target of $75.78, implying over 100% upside from the current price of roughly $36.29.
β‘ Oklo expects early isotope revenue to begin in the first part of next year from its Idaho lab operations.
ποΈ The DOE approved the preliminary safety analysis for the Aurora INL power plant, with startup targeted for 2028.
π€ Oklo signed a memorandum of understanding with Kiewit to develop a 1.2 gigawatt campus in Ohio.
π The company holds a 12 GW customer agreement with Switch, contributing to a total pipeline of approximately 14 GW.
β οΈ Management raised 2026 guidance for operating cash use to between $120 million and $150 million due to increased project spending.
π The stock has fallen 68.7% over the past year, trading at roughly 8x Nano Nuclear's market cap despite having a working reactor.
βοΈ Key risks include the total cost of the Aurora INL project, potential share sales via ATM programs totaling $1.9 billion in 2026, and pending agreements for fuel supply.
Bullish Signals
Groves reactor reached criticality in early August 2026.
Holds $3B cash covering 45% of market cap.
Analyst price target is $75.78 with upside.
Secured 12 GW customer deal with Switch.
DOE approved Aurora INL safety analysis for 2028.
Risk Factors
YTD net loss $81.6M through Q2 2026.
Raised 2026 cash use guidance to $120-150M.
Aurora INL project costs remain unfinalized.
DOE plutonium agreement delays risk profitability.
Bullish Signals
Oklo's Groves reactor reached first criticality in early August 2026, less than a year after construction began, validating its ability to build and operate commercial reactors.
The company possesses approximately $3 billion in cash and marketable securities, providing a substantial liquidity cushion that covers 45% of its market cap.
Analysts project a price target of $75.78 based on demonstrated performance and strong balance sheet, implying significant upside potential from current levels.
Oklo has secured a 12 GW customer agreement with Switch, representing a major portion of its approximately 14 GW total customer pipeline.
The DOE approved the preliminary safety analysis for the Aurora INL power plant, keeping the startup timeline on track for 2028.
Risk Factors
Oklo reported a year-to-date net loss of $81.6 million through Q2 2026, reflecting the high capital intensity of its development phase.
Management raised its 2026 guidance for operating cash use to between $120 million and $150 million due to increased spending on project construction.
The total cost for the Aurora INL project has not yet been finalized by management, creating uncertainty around future profitability.
Oklo's reliance on surplus plutonium from the DOE is contingent upon a final agreement being reached, which could delay or alter project economics.
Capital raisingCompany updateRegulatory approvalAI-generated analysis
Oklo Inc. (NYSE: OKLO) closed at $35.87 on October 2, 2026, reflecting a significant decline from its previous highs. The company recently reached a major technical milestone with the Groves Isotope Test Reactor in Texas achieving first criticality on August 5, 2026, under Department of Energy authorization. However, this reactor is distinct from the commercial Aurora-INL power plant project, which remains targeted for a 2028 launch and currently lacks an NRC operating license or startup authorization.
Oklo reported $1.21 million in revenue for the quarter ended June 30, 2026, driven entirely by engineering and consulting services rather than power sales, alongside a net loss of $48.5 million. Despite these losses, the company maintains a robust balance sheet with approximately $3 billion in cash, cash equivalents, and marketable securities as of June 30, providing substantial liquidity to fund operations and capital spending without immediate need for external financing.
To manage its cash position, Oklo terminated a previous $1 billion at-the-market (ATM) program on September 10 and signed a replacement agreement allowing it to sell up to another $1 billion through major financial institutions. The article analyzes three price scenarios based on this liquidity: a bullish case around $58 assuming the new ATM remains largely unused, a base case near $31, and a bearish case around $15 if significant dilution occurs or if the company spends down its cash reserves before generating commercial power revenue.
The article concludes that Oklo's stock valuation is currently priced on potential future power generation capabilities rather than current operational performance. Key upcoming catalysts include the quarterly reporting of ATM sales activity and regulatory progress on the Aurora-INL project, specifically seeking a DOE startup authorization or an NRC combined license application to move toward commercial deployment.
π Stock trades below $58 bull case after significant decline from October 2025 highs.
βοΈ Groves Isotope Test Reactor achieved first criticality on August 5, 2026.
π° Company holds $3 billion cash providing over one year of operational runway.
π Signed new agreement to sell up to $1 billion in shares via major banks.
π Oklo stock closed at $35.87, down significantly from its October 2025 highs, trading below the analyst-defined $58 bull case and above the $15 bear case.
βοΈ The Groves Isotope Test Reactor achieved first criticality on August 5, 2026, marking a technical success for Oklo's technology under DOE authorization.
π° Oklo holds approximately $3 billion in cash and securities as of June 30, 2026, providing over one year of operational runway without material commitments.
π The company reported a net loss of $48.5 million for the quarter ended June 30, 2026, with revenue of only $1.21 million derived from services.
π Oklo terminated its previous ATM program and signed a new agreement to sell up to $1 billion in shares through major banks like Goldman Sachs and J.P. Morgan.
ποΈ The commercial Aurora-INL power plant project remains on track for a 2028 target but has not yet received an NRC operating license or startup authorization.
π€ Oklo signed a letter of intent with Centrus for HALEU supply starting in 2029, contingent on definitive contract terms and prepayments.
π Analyst scenarios suggest the stock could trade at $58 if cash remains intact, or drop to $15 if significant dilution occurs before commercial revenue.
π The next critical filing will be the Q3 10-Q, which is expected to disclose whether Oklo has utilized its new $1 billion ATM program.
βοΈ Regulatory progress for Aurora-INL includes a preliminary safety analysis approval but lacks the final NRC combined license required for commercial operation.
Bullish Signals
Achieved first criticality at Groves Isotope Test Reactor on August 5, 2026.
Holds $3.0 billion cash and securities as of June 30, 2026.
Secured ATM program to raise up to $1 billion for operations.
Oklo achieved first criticality at the Groves Isotope Test Reactor on August 5, 2026, demonstrating technical validation of its reactor design under DOE authorization.
The company maintains a strong balance sheet with $3.0 billion in cash and securities as of June 30, 2026, providing ample liquidity to fund operations and capital projects.
Oklo secured a new at-the-market (ATM) program allowing it to raise up to $1 billion through major investment banks to support working capital and capital spending.
Risk Factors
Oklo reported a net loss of $48.5 million for the quarter ended June 30, 2026, with revenue limited to $1.21 million from non-power services.
Oklo's current stock price does not reflect the value of its unbuilt plants, and the company faces potential dilution if it sells a significant portion of its new $1 billion ATM program.
We use cookies to run the site and, only if you allow it, for live chat, analytics, personalization and ad measurement.
We use cookies to:
Deliver and maintain our services, protect against spam, fraud and abuse
Offer a live chat with our team (Enuchat, optional)
Measure audience engagement and site statistics to understand how our services are used (Google Analytics, optional)
Remember your quiz progress and tailor the knowledge base to your skill level (optional)
Measure how our ads on Facebook and Instagram perform, including whether a visit leads to a confirmed sign-up, matched to your Facebook or Instagram account using hashed contact details you enter (Meta Pixel, optional)
Optional cookies are only set if you allow them. You can accept all, reject all or choose per category, and change your choice at any time via the "Manage Cookies" link in the footer. Google and Meta may process this data in the USA. More in our Privacy Policy.
Manage cookie preferences
Necessary cookiesAlways active
Required for the website to function. These cannot be disabled.
Cookie
Purpose
Duration
PHPSESSID
Session identifier for login, security tokens, and site functionality
Session
cookie_consent
Stores your cookie preferences
1 year
Functional cookies
Show the live chat button so you can message our team. The Enuchat chat widget stores a visitor ID in your browser and sends your chat messages to Enuchat. When this is off, the chat is not loaded.
Cookie
Purpose
Duration
enuchat_visitor_id
Keeps your chat conversation linked to this browser (Enuchat, browser storage)
Until you clear it or turn this off
Analytics cookies
Help us understand how visitors use our website with Google Analytics, provided by Google LLC. Google receives pages visited, device data and an IP address, and may process them in the USA. If you also allow marketing cookies, the Google tag can detect contact details you enter or see on our pages, such as your email address, phone number, name or address, hash them before sending and pass them to Google so it can match your visits to a Google account for measuring our ads. Hashed details are still personal data. See how Google uses information from sites that use its services.
Cookie
Purpose
Duration
_ga
Distinguishes unique visitors (Google Analytics)
2 years
_ga_*
Maintains session state (Google Analytics)
2 years
Personalization cookies
Remember your quiz progress and work out your investing level so we can recommend knowledge-base articles and the right reading depth for you. Stored only on your device.
Cookie
Purpose
Duration
bes_user_level
Your quiz-derived investing level, used to tailor content
1 year
Marketing cookies
Let Meta (Facebook and Instagram) measure how our ads perform, using the Meta Pixel. Meta Platforms Ireland Ltd. receives the pages you visit and, when you confirm the email address of a new account, a "completed registration" event, together with browser identifiers and your IP address. Meta's automatic advanced matching also reads contact details you type into forms on our site, such as your email address or name, hashes them in your browser and sends them with these events so Meta can match them to a Facebook or Instagram account. Hashed details are still personal data. These events are sent from your browser and may also be forwarded to Meta through Meta's Conversions API Gateway. Our own server also sends page visits and completed-registration events directly to Meta's Conversions API, with your IP address, browser user agent and Meta browser identifiers, so Meta can count it once. To help Meta match these visits, your browser and our server also send a random visitor ID from our own cookie and, if you are signed in, your account ID, your confirmed email address and the name, city, postal code and country saved in your profile, all hashed first. We and Meta are joint controllers for collecting and sending this data, and Meta's further use, which may include processing in the USA, is described in the Meta Privacy Policy. When this is off, the Meta Pixel is not loaded and no page visit or registration event is sent to Meta. Together with analytics cookies, this choice also lets Google receive hashed contact details, as described under Analytics cookies.
Cookie
Purpose
Duration
_fbp
Identifies browsers for Meta ad measurement (Meta Pixel)
3 months
_fbc
Stores the Meta ad click that brought you here (Meta Pixel)
3 months
_bes_meid
Random visitor ID, sent to Meta only hashed, so your visits can be matched (Meta Pixel and Conversions API)